Dr Giuseppe Tavormina, M.D. – Psychiatrist

President of Cen.Stu.Psi. - Psychiatric Studies Centre

Senior Research Fellow Bedforshire Centre Mental Health & University of Cambridge

  Scientific Publications

  1. Figar M, Marini F, Tavormina G, et al - "Percorsi dell'urgenza in Psichiatria: lo psichiatra tra il comprendere e l'agire" (Giornale Veneto di Scienze Mediche, 1992; 44: suppl 4: 39-45);
  2. Tavormina G - "Il ruolo della Fluvoxamina nel disturbo bipolare dell'umore di tipo misto" (Neuronius, 1999; 1: 3-4);
  3. Tavormina G - "Variabilità di utilizzo del Citalopram e sua tollerabiltà" (Giornale Italiano di Psicopatologia, 2000; 6: suppl 1: 262);
  4. Tavormina G - "Utilizzo della Gabapentina negli stati misti dei disturbi dell'umore con disritmie all'EEG" (Giornale Italiano di Psicopatologia, 2000; 6: suppl 1: 262-3);
  5. Tavormina G - "Efficacy and tolerability of Mirtazapine in bipolar spectrum depression" (The International Journal of Neuropsychopharmacology, 2000; 3: suppl 1: 194);
  6. Tavormina G - "Oxcarbazepine as a mood regulator: its efficacy, safety and tolerability vs Carbamazepine" (The International Journal of Neuropsychopharmacology, 2000; 3: suppl 1: 337);
  7. Tavormina G - "Utilizzo del Risperidone nei gravi disturbi dell’umore dello spettro bipolare" (Giornale Italiano di Psicopatologia, 2001; 7: suppl 1: 235-6);
  8. Tavormina G - "Bright light treatment for women’s mental health: four cases reports" (Archives of Women’s Mental Health, 2001; 3: suppl 2: 94);
  9. Tavormina G, Corea S, Sirianni P, Tavormina M - "Mood or anxious diseases of the significant others of patients with mood or anxious diseases" (The World Journal of Biological Psychiatry, 2001; 2: suppl 1: 207);
  10. Tavormina G - "Bright light therapy as an antidepressant modality" (The World Journal of Biological Psychiatry, 2001; 2: suppl 1: 341);
  11. Tavormina G, Corea S - "Psychiatric Studies Centre" (The World Journal of Biological Psychiatry, 2001; 2: suppl 1: 376);
  12. Tavormina G - "Efficacy of Fluvoxamine in depression of cyclothymic older patients" (International Psychogeriatrics, 2001; 13: suppl 2: 185);
  13. Tavormina G - "Ropinirole as an antidepressant: its efficacy and tolerability" (Actas Espagnolas de Psiquiatria, 2001; 29: suppl 1: 306);
  14. Tavormina G - "Variability of Mirtazapine utilization" (Actas Espagnolas de Psiquiatria, 2001; 29: suppl 1: 306).
  15. Tavormina G - "Il Ropinirolo come un antidepressivo: sua efficacia e tollerabilità" (Giornale Italiano di Psicopatologia , 2002; 8: suppl 1: 199);
  16. Tavormina G - "Citalopram efficacy in PAD and OCD disorders" (European Psychiatry, 2002; 17: suppl 1: 95);
  17. Tavormina G, Corea S - "Il CEN.STU.PSI., Centro Studi Psichiatrici – Provaglio d’Iseo", (Studi di Psichiatria, 2002; 4: 5);
  18. Tavormina G - "Venlafaxine utilization in mood disorders with resistant depressive symptoms" (The World Journal of Biological Psychiatry, 2002; 3: suppl 1: 28);
  19. Tavormina G, Corea S, Citron A - "Reboxetine utilization as add-on terapy to SSRI in treatment-resistant depression" (J Clin Psychiatry, 2002; 63:11, 1082);
  20. Tavormina G - "Efficacia di Fluvoxamina in pazienti anziani ciclotimici affetti da depressione" (Medico e paziente, 2002; 8: suppl 1: 3-4);
  21. Tavormina G, Corea S, Sirianni P, Tavormina M - "Disturbi dell’umore o d’ansia nei partners dei pazienti con disturbi dell’umore o d’ansia" (Journal on line, Psichiatria, 2002; 23: 4);
  22. Tavormina G - "Utilizzo della Venlafaxina nei disturbi dell’umore con sintomatologia depressiva resistente" (Journal on line, Psichiatria, 2002; 24: 4);
  23. Tavormina G - "Uso della Terapia della Luce in varie patologie psichiatriche" (Journal on line, Psichiatria, 2002; 25: 4);
  24. Tavormina G - "L’Oxcarbazepina come regolatore dell’umore: sua efficacia e tolerabilità vs. la Carbamazepina" (Giornale Italiano di Psicopatologia, 2003; 9: suppl 1: 305);
  25. Tavormina G, Corea S, Citron A - "Mood or anxious diseases of the significant others of psichiatric patients" (European Psychiatry, 2004; 19: suppl 1: 186);
  26. Tavormina G - "Bright light therapy in various psychiatric diseases" (Psychiatriki, 2004; 15: suppl 1: 183);
  27. Tavormina G, Costigliola V - "European Depression Day" (Psychiatriki, 2004; 15: suppl 1: 184);
  28. Tavormina G -"Risperidone utilization in serious bipolar mood disorders" (European Psychiatry, 2005; 20: suppl 1: 142);
  29. Tavormina G, Corea S, Citron A -"The prevalence of psychiatric disease in the significant others of patients with known mood and anxious disease" (Clinical Practice and Epidemiology in Mental Health 2005; 1:12; 02 Aug 2005);
  30. Tavormina G - "Depressione e ansia in gravidanza: ruolo della terapia della luce" (Giornale Italiano di Psicopatologia , 2006; 12: suppl 1: 411-412);
  31. Zdanowicz N, Tavormina G, Agius M, et al -"Actual emergency in psychiatry: from everyday problems to crisis" (European Psychiatry, 2006; 21: suppl 1: 170-1);
  32. Tavormina G -"Depression and anxiety during pregnancy: the role of light therapy" (European Psychiatry, 2007; 22: suppl 1: 66);
  33. Agius M, Tavormina G - "Identifying and treating bipolar illness early" (BMJ, February 19th , 2007);
  34. Tavormina G, Agius M - "Need to improve diagnosis and treatment for bipolar disorder" (Br J Psych, 2007; 190: 189-191);
  35. Agius M, Tavormina G, Zaman R, et al - "Developing primary care treatment of depression" (Br J General Practice, 2007; 57: 501-2);
  36. Tavormina G, Agius M - "The high prevalence of the bipolar spectrum in private practice" (J Bipolar Dis: Rev & Comm, 2007; 6; 3: 19);
  37. Tavormina G - "Bipolar spectrum diagnosis and social aspects of mood disorders: the European Depression Day project" (Psychiatria Danubina, 2007; 19: suppl 1: 6);
  38. Tavormina G - "Light therapy in pregnant women with depression ad anxiety" (Psychiatria Danubina, 2007; 19: suppl 1: 58);
  39. Tavormina G, Agius M - "A study of the incidence of bipolar spectrum disorders in a private psychiatric practice" (Psychiatria Danubina, 2007; 19: 4: 370-74);
  40. Zdanowicz N, Tavormina G, Agius M - "Must the risk of side effects dictate pharmacological practices?" (European Psychiatry, 2008; 23: suppl 2: 171);
  41. Agius M, Tavormina G, Zaman R, et al - "Under diagnosis of bipolar affective disorder in an English community mental health team" (European Psychiatry, 2008; 23: suppl 2: 224);
  42. Agius M, Tavormina G - "The bipolar spectrum: do we need a single algorithm for affective disorder?" (European Psychiatry, 2009; 24: suppl 1: P01-218);
  43. Tavormina G - "Le Dipendenze nello Spettro Bipolare e i suoi aspetti psico-educazionali: La Giornata Europea sulla Depressione" (La Fenice, Journal of Addictions, 2009; 1:1-2; Aug 2009;
  44. Tavormina G - "The bipolar spectrum diagnosis: the role of the temperaments" (Psychiatria Danubina, 2009; 21: 2: 160-161);
  45. Tavormina G - "The temperaments and their role in early diagnosis of bipolar spectrum disorders" (Psychiatria Danubina, 2010; 22, suppl 1: 15-17);
  46. Tavormina G – "The temperaments: its knowledge is a crucial way in early diagnosis of bipolar disorders" (European Psychiatry, 2011; 26: suppl 1: P01-199).;
  47. Tavormina G – "Are somatisations symptoms important evidence for an early diagnosis of bipolar spectrum mood disorders?" (Psychiatria Danubina, 2011; 23: suppl 1: 13-14)
  48. Tavormina G – "An approach to the diagnosis and treatment of patients with bipolar spectrum mood disorders, identifying temperaments" (Psychiatria Danubina, 2012; 24: suppl 1: 25-27);
  49. Tavormina G – "An early diagnosis of bipolar spectrum disorders needs of valuing the somatisation symptoms of patients" (J Int Clin Psychopharmacol, 2012; 28: e59-e60);
  50. Tavormina G – Consulting Editor issue 3 of Cutting Edge Psychiatry in Practice (CEPIP) – The management of bipolar spectrum disorder – (SEPT) --- august 2013.
  51. Tavormina G – "An introduction to the bipolar spectrum" - The management of bipolar spectrum disorder (CEPIP); august 2013; 3-6.
  52. Tavormina G – "The temperaments and their relevance to bipolar spectrum disorders" - The management of bipolar spectrum disorder (CEPIP); august 2013; 19-21.
  53. Tavormina G – "Some somatic symptoms are important evidence for an early diagnosis of bipolar spectrum mood disorders" - The management of bipolar spectrum disorder (CEPIP); august 2013; 192-94.
  54. Tavormina G – "A clinical diagnostic-therapeutic long time evaluation of 30 cases reports of bipolar spectrum mixed states" (Psychiatria Danubina, 2013; 25: suppl 2: 190-93.
  55. Tavormina G, et al – "Luce sul male oscuro - Throwing light on a dark problem" (Sardini Editore), september 2013.
  56. Tavormina G. “Treating the bipolar spectrum mixed states: a new rating scale to diagnose them”. (Psychiatria Danubina 2014; 26 (supp 1), 6-9).
  57.  Tavormina G – “Clinical utilisation of the ‘GT-MSRS’, the rating scale for mixed states: 35 cases report”. (Psychiatria Danubina, 2015; 27: supp 1: 155-59).
  58. Tavormina MGM, Tavormina R, Tavormina G, Nemoianni E – “A questionnaire to assess social stigma”. (Psychiatria Danubina, 2015; 27: supp 1: 328-331).
  59. Tavormina G – “An approach to treat bipolar disorders mixed states”. (Psychiatria Danubina, 2016; 28: supp 1: 9-12).
  60. Tavormina MGM, Tavormina G, Tavormina R, et al. – “Thinking of psychiatric disorders as a ‘normal’ illness”. (Psychiatria Danubina, 2016; 28: supp 1: 125-131).
  61. Tavormina G, et al.- Clinical utilisation and usefullness of the rating scale of mixed states, (“GT- MSRS”): a multicenter study. (Psychiatria Danubina, 2017; 29: supp 3: 365-67).
  62. Tavormina G – “Il trattamento degli stati misti: nuove proposte per nuove linee-guida”. (Telos, 2017; supp ottobre 2017: 7-13).
  63. Tavormina MGM, Tavormina G e Tavormina R – “Malattia mentale e pregiudizi: studio multicentrico sullo stigma sociale”. (Telos, 2017; supp ottobre 2017: 61-70).
  64.  Tavormina G - How understanding the temperaments can help clinicians to make a correct diagnosis of bipolar mood disorders: 10 case reports - (Psychiatria Danubina, 2018; 30: supp 7: 398-400). 
  65.  Tavormina G - Can writing poems and taking photos help the psychiatrist to improve his humanity and the mental health of his patients? - (Psychiatria Danubina, 2018; 30: supp 7: 648).